Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)

Compare
26.33
+1.06
+(4.19%)
At close: April 3 at 3:00:02 PM GMT+8
Loading Chart for 600993.SS
  • Previous Close 25.27
  • Open 25.45
  • Bid 26.33 x --
  • Ask 26.34 x --
  • Day's Range 25.27 - 26.63
  • 52 Week Range 21.33 - 31.18
  • Volume 20,453,380
  • Avg. Volume 5,865,756
  • Market Cap (intraday) 11.35B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 21.41
  • EPS (TTM) 1.23
  • Earnings Date --
  • Forward Dividend & Yield 0.40 (1.52%)
  • Ex-Dividend Date Jul 26, 2024
  • 1y Target Est --

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical products comprising anorectal postoperative care, daily electronic auxiliary products, eye device care, disinfection and sterilization, etc. In addition, the company is involved in the development, production, and sale of pharmaceutical products; retail and wholesale of medical devices and drugs; provision of hospital medical and management service; and hospital operations. It sells its products through online stores. Mayinglong Pharmaceutical Group Co., Ltd., was founded in 1582 and is headquartered in Wuhan, China.

www.mayinglong.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600993.SS

View More

Performance Overview: 600993.SS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600993.SS
0.84%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

600993.SS
15.94%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

600993.SS
22.31%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

600993.SS
87.22%
SSE Composite Index (000001.SS)
20.91%

Compare To: 600993.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600993.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    11.35B

  • Enterprise Value

    8.43B

  • Trailing P/E

    21.41

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.03

  • Price/Book (mrq)

    2.79

  • Enterprise Value/Revenue

    2.26

  • Enterprise Value/EBITDA

    11.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.17%

  • Return on Assets (ttm)

    7.73%

  • Return on Equity (ttm)

    13.59%

  • Revenue (ttm)

    3.73B

  • Net Income Avi to Common (ttm)

    528.09M

  • Diluted EPS (ttm)

    1.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.16B

  • Total Debt/Equity (mrq)

    5.57%

  • Levered Free Cash Flow (ttm)

    216.13M

Research Analysis: 600993.SS

View More

Company Insights: 600993.SS

Research Reports: 600993.SS

View More

People Also Watch